Form 4: Anavex Life Sciences Executive Receives Stock Grant
Insider Transaction (Form 4)
Sandra Boenisch, PFO & Treasurer of Anavex Life Sciences Corp., reported multiple transactions in common stock on September 24, 2026.
Summary
- Grant/award: acquired 20,000 Stock Option (Right to Buy) on September 24, 2026; holds 20,000 after (Direct).
- Grant/award: acquired 25,000 Stock Option (Right to Buy) on September 24, 2026; holds 25,000 after (Direct).
- Grant/award: acquired 25,000 Stock Option (Right to Buy) on September 24, 2026; holds 25,000 after (Direct).
- Grant/award: acquired 25,000 Stock Option (Right to Buy) on September 24, 2026; holds 25,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sandra Boenisch — Officer (PFO & Treasurer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-24 | Grant/award | Stock Option (Right to Buy) | 20,000 | — | — | 20,000 |
| 2026-09-24 | Grant/award | Stock Option (Right to Buy) | 25,000 | — | — | 25,000 |
| 2026-09-24 | Grant/award | Stock Option (Right to Buy) | 25,000 | — | — | 25,000 |
| 2026-09-24 | Grant/award | Stock Option (Right to Buy) | 25,000 | — | — | 25,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-24 | Grant/award (20,000 shares) |
| 2026-09-24 | Grant/award (25,000 shares) |
| 2026-09-24 | Grant/award (25,000 shares) |
| 2026-09-24 | Grant/award (25,000 shares) |
Keywords
insider transaction, Form 4, AVXL, ANAVEX LIFE SCIENCES CORP., neutral, Sandra Boenisch
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.